An international multicentre analysis of current prescribing practices and shared decision-making in psoriatic arthritis.

ABSTRACT:

Objectives

Shared decision-making (SDM) is advocated to improve patient outcomes in PsA. We analysed current prescribing practices and the extent of SDM in PsA across Europe.

Methods

The ASSIST study was a cross-sectional observational study of PsA patients ≥18 years of age attending face-to-face appointments between July 2021 and March 2022. Patient demographics, current treatment and treatment decisions were recorded. SDM was measured by the clinician's effort to collaborate (CollaboRATE questionnaire) and patient communication confidence (PEPPI-5 tool).

Results

A total of 503 patients were included from 24 centres across the UK, France, Germany, Italy and Spain. Physician- and patient-reported measures of disease activity were highest in the UK. Conventional synthe

SUBMITTER: Watson L 

PROVIDER: S-EPMC11636566 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature